Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 396

1.

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.

Simon JA, Kingsberg SA, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Clayton AH.

Obstet Gynecol. 2019 Oct 8. doi: 10.1097/AOG.0000000000003514. [Epub ahead of print]

PMID:
31599847
2.

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.

Kingsberg SA, Clayton AH, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Simon JA.

Obstet Gynecol. 2019 Oct 8. doi: 10.1097/AOG.0000000000003500. [Epub ahead of print]

PMID:
31599840
3.

Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopause.

Archer DF, Simon JA, Portman DJ, Goldstein SR, Goldstein I.

Expert Rev Endocrinol Metab. 2019 Sep;14(5):301-314. doi: 10.1080/17446651.2019.1657008. Epub 2019 Sep 17.

PMID:
31526199
4.

Effects of Timing of Flibanserin Administration Relative to Alcohol Intake in Healthy Premenopausal Women: A Randomized, Double-Blind, Crossover Study.

Simon JA, Clayton AH, Kingsberg SA, Parish SJ, Kim NN, Millheiser L.

J Sex Med. 2019 Sep 12. pii: S1743-6095(19)31365-7. doi: 10.1016/j.jsxm.2019.08.006. [Epub ahead of print]

PMID:
31522985
5.

Safety and Tolerability of Evening Ethanol Consumption and Bedtime Administration of Flibanserin in Healthy Premenopausal Female Subjects.

Millheiser L, Clayton AH, Parish SJ, Kingsberg SA, Kim NN, Simon JA.

Sex Med. 2019 Sep 10. pii: S2050-1161(19)30127-8. doi: 10.1016/j.esxm.2019.08.003. [Epub ahead of print]

6.

Global Consensus Position Statement on the Use of Testosterone Therapy for Women.

Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME.

J Clin Endocrinol Metab. 2019 Oct 1;104(10):4660-4666. doi: 10.1210/jc.2019-01603.

PMID:
31498871
7.

Global Consensus Position Statement on the Use of Testosterone Therapy for Women.

Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME.

J Sex Med. 2019 Sep;16(9):1331-1337. doi: 10.1016/j.jsxm.2019.07.012.

PMID:
31488288
8.

Global Consensus Position Statement on the use of Testosterone Therapy for Women.

Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME.

Maturitas. 2019 Oct;128:89-93. doi: 10.1016/j.maturitas.2019.07.001. Epub 2019 Sep 1. No abstract available.

PMID:
31484631
9.

Pattern of latrine use by domestic cats on dairy farms and the implications for Toxoplasma gondii transmission.

Simon JA, Chancel E, Hubert P, Aubert D, Villena I, Gilot-Fromont E, Poulle ML.

Vet Parasitol. 2019 Sep;273:112-121. doi: 10.1016/j.vetpar.2019.08.001. Epub 2019 Aug 11.

PMID:
31476666
10.

Global Consensus Position Statement on the Use of Testosterone Therapy for Women.

Davis SR, Baber R, Panay N, Bitzer J, Cerdas Perez S, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME.

Climacteric. 2019 Oct;22(5):429-434. doi: 10.1080/13697137.2019.1637079. Epub 2019 Sep 2. No abstract available. Erratum in: Climacteric. 2019 Dec;22(6):637.

PMID:
31474158
11.

Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices.

Goldstein I, Simon JA, Kaunitz AM, Altomare C, Yoshida Y, Zhu J, Schaffer S, Soulban G.

Menopause. 2019 Sep;26(9):994-1001. doi: 10.1097/GME.0000000000001350.

12.

The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 kinase via pyrimidine depletion.

Dembitz V, Tomic B, Kodvanj I, Simon JA, Bedalov A, Visnjic D.

J Biol Chem. 2019 Aug 20. pii: jbc.RA119.009396. doi: 10.1074/jbc.RA119.009396. [Epub ahead of print]

13.

ORC-13661 protects sensory hair cells from aminoglycoside and cisplatin ototoxicity.

Kitcher SR, Kirkwood NK, Camci ED, Wu P, Gibson RM, Redila VA, Simon JA, Rubel EW, Raible DW, Richardson GP, Kros CJ.

JCI Insight. 2019 Aug 8;4(15). pii: 126764. doi: 10.1172/jci.insight.126764. eCollection 2019 Aug 8.

14.

Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.

Bilezikian JP, Lin CJF, Brown JP, Wang AT, Yin X, Ebeling PR, Fahrleitner-Pammer A, Franek E, Gilchrist N, Miller PD, Simon JA, Valter I, Zerbini CAF, Libanati C, Chines A.

Osteoporos Int. 2019 Sep;30(9):1855-1864. doi: 10.1007/s00198-019-05020-8. Epub 2019 Jun 14.

15.

Weight Loss in Women Taking Flibanserin for Hypoactive Sexual Desire Disorder (HSDD): Insights Into Potential Mechanisms.

Simon JA, Kingsberg SA, Goldstein I, Kim NN, Hakim B, Millheiser L.

Sex Med Rev. 2019 Oct;7(4):575-586. doi: 10.1016/j.sxmr.2019.04.003. Epub 2019 Jun 10. Review.

PMID:
31196764
16.

Fate plasticity and reprogramming in genetically distinct populations of Danio leucophores.

Lewis VM, Saunders LM, Larson TA, Bain EJ, Sturiale SL, Gur D, Chowdhury S, Flynn JD, Allen MC, Deheyn DD, Lee JC, Simon JA, Lippincott-Schwartz J, Raible DW, Parichy DM.

Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11806-11811. doi: 10.1073/pnas.1901021116. Epub 2019 May 28.

17.

Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices.

Goldstein I, Simon JA, Kaunitz AM, Altomare C, Yoshida Y, Zhu J, Schaffer S, Soulban G.

Menopause. 2019 May 20. doi: 10.1097/GME.0000000000001350. [Epub ahead of print]

PMID:
31124912
18.

TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women.

Simon JA, Kagan R, Archer DF, Constantine GD, Bernick B, Graham S, Mirkin S.

Climacteric. 2019 Aug;22(4):412-418. doi: 10.1080/13697137.2019.1577379. Epub 2019 Mar 12.

PMID:
30862193
19.

Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part III.

Parish SJ, Meston CM, Althof SE, Clayton AH, Goldstein I, Goldstein SW, Heiman JR, McCabe MP, Segraves RT, Simon JA.

J Sex Med. 2019 Mar;16(3):452-462. doi: 10.1016/j.jsxm.2019.01.010.

PMID:
30846116
20.

Descriptors of Vulvodynia: A Multisocietal Definition Consensus (International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women Sexual Health, and the International Pelvic Pain Society).

Bornstein J, Preti M, Simon JA, As-Sanie S, Stockdale CK, Stein A, Parish SJ, Radici G, Vieira-Baptista P, Pukall C, Moyal-Barracco M, Goldstein A; International Society for the Study of Vulvovaginal Disease (ISSVD), the International Society for the Study of Womenʼs Sexual Health (ISSWSH), and the International Pelvic Pain Society (IPPS).

J Low Genit Tract Dis. 2019 Apr;23(2):161-163. doi: 10.1097/LGT.0000000000000461.

PMID:
30768446
21.

Female Sexual Health: Barriers to Optimal Outcomes and a Roadmap for Improved Patient-Clinician Communications.

Kingsberg SA, Schaffir J, Faught BM, Pinkerton JV, Parish SJ, Iglesia CB, Gudeman J, Krop J, Simon JA.

J Womens Health (Larchmt). 2019 Apr;28(4):432-443. doi: 10.1089/jwh.2018.7352. Epub 2019 Feb 4.

22.

Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.

Simon JA, Thorp J, Millheiser L.

J Womens Health (Larchmt). 2019 Jun;28(6):769-777. doi: 10.1089/jwh.2018.7516. Epub 2019 Feb 1.

PMID:
30707049
23.

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial.

Archer DF, Goldstein SR, Simon JA, Waldbaum AS, Sussman SA, Altomare C, Zhu J, Yoshida Y, Schaffer S, Soulban G.

Menopause. 2019 Jan 28;26(6):611-621. doi: 10.1097/GME.0000000000001292.

24.

Women's experience of vulvovaginal symptoms associated with menopause.

Shifren JL, Zincavage R, Cho EL, Magnavita A, Portman DJ, Krychman ML, Simon JA, Kingsberg SA, Rosen RC.

Menopause. 2019 Apr;26(4):341-349. doi: 10.1097/GME.0000000000001275.

PMID:
30531443
25.

Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms.

Constantine GD, Revicki DA, Kagan R, Simon JA, Graham S, Bernick B, Mirkin S.

Menopause. 2019 May;26(5):513-519. doi: 10.1097/GME.0000000000001261.

26.

Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.

Simon JA, Kaunitz AM, Kroll R, Graham S, Bernick B, Mirkin S.

Menopause. 2019 May;26(5):506-512. doi: 10.1097/GME.0000000000001271.

27.

Female Sexual Dysfunction and the Placebo Effect: A Meta-analysis.

Kingsberg S, Goldstein I, Kim NN, Simon JA.

Obstet Gynecol. 2018 Dec;132(6):1504. doi: 10.1097/AOG.0000000000002985. No abstract available.

PMID:
30461675
28.

Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.

Carr BR, Stewart EA, Archer DF, Al-Hendy A, Bradley L, Watts NB, Diamond MP, Gao J, Owens CD, Chwalisz K, Duan WR, Soliman AM, Dufek MB, Simon JA.

Obstet Gynecol. 2018 Nov;132(5):1252-1264. doi: 10.1097/AOG.0000000000002933.

PMID:
30303923
29.

Wearable Cardioverter-Defibrillator after Myocardial Infarction.

Olgin JE, Pletcher MJ, Vittinghoff E, Wranicz J, Malik R, Morin DP, Zweibel S, Buxton AE, Elayi CS, Chung EH, Rashba E, Borggrefe M, Hue TF, Maguire C, Lin F, Simon JA, Hulley S, Lee BK; VEST Investigators.

N Engl J Med. 2018 Sep 27;379(13):1205-1215. doi: 10.1056/NEJMoa1800781.

30.

Estradiol vaginal inserts (4 µg and 10 µg) for treating moderate to severe vulvar and vaginal atrophy: a review of phase 3 safety, efficacy and pharmacokinetic data.

Constantine GD, Simon JA, Pickar JH, Archer DF, Bernick B, Graham S, Mirkin S.

Curr Med Res Opin. 2018 Dec;34(12):2131-2136. doi: 10.1080/03007995.2018.1527578. Epub 2018 Sep 28.

PMID:
30238814
31.

In Reply.

Faubion SS, Larkin LC, Simon JA, Kingsberg SA.

Menopause. 2019 Feb;26(2):227-228. doi: 10.1097/GME.0000000000001191. No abstract available.

PMID:
30204639
32.

Sexual well-being after menopause: An International Menopause Society White Paper.

Simon JA, Davis SR, Althof SE, Chedraui P, Clayton AH, Kingsberg SA, Nappi RE, Parish SJ, Wolfman W.

Climacteric. 2018 Oct;21(5):415-427. doi: 10.1080/13697137.2018.1482647. Epub 2018 Jul 10. Review.

PMID:
29987939
33.

In Reply.

Simon JA.

Obstet Gynecol. 2018 Jul;132(1):215-216. doi: 10.1097/AOG.0000000000002704. No abstract available.

PMID:
29939916
34.

Treatments for Hypoactive Sexual Desire Disorder (HSDD) and the Pursuit of Sexual Health for Women amidst Inglorious Rhetoric.

Kim NN, Goldstein I, Larkin L, Kellogg-Spadt S, Simon JA.

Sex Med Rev. 2018 Jul;6(3):339-342. doi: 10.1016/j.sxmr.2018.06.001. Epub 2018 Jun 15. No abstract available.

PMID:
29914753
35.

Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies.

Surrey E, Taylor HS, Giudice L, Lessey BA, Abrao MS, Archer DF, Diamond MP, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Singh SS, Rechberger T, Agarwal SK, Duan WR, Schwefel B, Thomas JW, Peloso PM, Ng J, Soliman AM, Chwalisz K.

Obstet Gynecol. 2018 Jul;132(1):147-160. doi: 10.1097/AOG.0000000000002675. Erratum in: Obstet Gynecol. 2018 Dec;132(6):1507-1508.

PMID:
29889764
36.

A multi-event capture-recapture analysis of Toxoplasma gondii seroconversion dynamics in farm cats.

Simon JA, Pradel R, Aubert D, Geers R, Villena I, Poulle ML.

Parasit Vectors. 2018 Jun 8;11(1):339. doi: 10.1186/s13071-018-2834-4.

37.

The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review.

Simon JA, Goldstein I, Kim NN, Davis SR, Kellogg-Spadt S, Lowenstein L, Pinkerton JV, Stuenkel CA, Traish AM, Archer DF, Bachmann G, Goldstein AT, Nappi RE, Vignozzi L.

Menopause. 2018 Jul;25(7):837-847. doi: 10.1097/GME.0000000000001138.

PMID:
29870471
38.

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health.

Faubion SS, Larkin LC, Stuenkel CA, Bachmann GA, Chism LA, Kagan R, Kaunitz AM, Krychman ML, Parish SJ, Partridge AH, Pinkerton JV, Rowen TS, Shapiro M, Simon JA, Goldfarb SB, Kingsberg SA.

Menopause. 2018 Jun;25(6):596-608. doi: 10.1097/GME.0000000000001121.

PMID:
29762200
39.

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting.

Afram G, Simón JAP, Remberger M, Caballero-Velázquez T, Martino R, Piñana JL, Ringden O, Esquirol A, Lopez-Corral L, Garcia I, López-Godino O, Sierra J, Caballero D, Ljungman P, Vazquez L, Hägglund H.

Med Oncol. 2018 Apr 25;35(6):79. doi: 10.1007/s12032-018-1127-2.

40.

Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause.

Traish AM, Vignozzi L, Simon JA, Goldstein I, Kim NN.

Sex Med Rev. 2018 Oct;6(4):558-571. doi: 10.1016/j.sxmr.2018.03.005. Epub 2018 Apr 7. Review.

41.

Inhibition of vaccinia virus replication by nitazoxanide.

Hickson SE, Margineantu D, Hockenbery DM, Simon JA, Geballe AP.

Virology. 2018 May;518:398-405. doi: 10.1016/j.virol.2018.03.023. Epub 2018 Apr 3.

42.

Perioperative Care of the Breastfeeding Patient.

Simon JA, Carabetta M, Rieth EF, Barnett KM.

AORN J. 2018 Apr;107(4):465-474. doi: 10.1002/aorn.12101.

PMID:
29595905
43.

The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women.

Clayton AH, Goldstein I, Kim NN, Althof SE, Faubion SS, Faught BM, Parish SJ, Simon JA, Vignozzi L, Christiansen K, Davis SR, Freedman MA, Kingsberg SA, Kirana PS, Larkin L, McCabe M, Sadovsky R.

Mayo Clin Proc. 2018 Apr;93(4):467-487. doi: 10.1016/j.mayocp.2017.11.002. Epub 2018 Mar 12. Review.

44.

Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.

Simon JA, Derogatis L, Portman D, Brown L, Yuan J, Kissling R.

J Sex Med. 2018 Mar;15(3):387-395. doi: 10.1016/j.jsxm.2017.12.016.

PMID:
29502984
45.

Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial.

Simon JA, Catherino W, Segars JH, Blakesley RE, Chan A, Sniukiene V, Al-Hendy A.

Obstet Gynecol. 2018 Mar;131(3):431-439. doi: 10.1097/AOG.0000000000002462.

PMID:
29420395
46.

Sexual Function Post-Breast Cancer.

Streicher L, Simon JA.

Cancer Treat Res. 2018;173:167-189. doi: 10.1007/978-3-319-70197-4_11. Review.

PMID:
29349764
47.

Implementation and Organization of a Perioperative Lactation Program: A Descriptive Study.

Rieth EF, Barnett KM, Simon JA.

Breastfeed Med. 2018 Mar;13(2):97-105. doi: 10.1089/bfm.2017.0193. Epub 2017 Dec 22.

48.

A Role for Monomethylation of Histone H3-K27 in Gene Activity in Drosophila.

Wang L, Joshi P, Miller EL, Higgins L, Slattery M, Simon JA.

Genetics. 2018 Mar;208(3):1023-1036. doi: 10.1534/genetics.117.300585. Epub 2017 Dec 14.

49.

Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14.

Kingsberg SA, Althof S, Simon JA, Bradford A, Bitzer J, Carvalho J, Flynn KE, Nappi RE, Reese JB, Rezaee RL, Schover L, Shifrin JL.

J Sex Med. 2017 Dec;14(12):1463-1491. doi: 10.1016/j.jsxm.2017.05.018. Review. Erratum in: J Sex Med. 2018 Feb;15(2):270.

PMID:
29198504
50.

Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials.

Simon JA, Altomare C, Cort S, Jiang W, Pinkerton JV.

J Womens Health (Larchmt). 2018 Jan;27(1):14-23. doi: 10.1089/jwh.2017.6385. Epub 2017 Oct 24.

Supplemental Content

Loading ...
Support Center